@ARTICLE{
author={Gossec Laure,Damjanov Nemanja S,Tsuji Shigeyoshi,Lertratanakul Apinya,Lippe Ralph,Patel Janki,Zueger Patrick,De Vlam K},
year={2022},
title={Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={81},
number={},
pages={1569-1570},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Gossec Laure,Damjanov Nemanja S,Tsuji Shigeyoshi,Lertratanakul Apinya,Lippe Ralph,Patel Jayeshkumar,Zueger Patrick,De Vlam Kurt},
year={2021},
title={Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={73},
number={},
pages={3986-3989},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Gladman Dafna,Mease Philip,Soriano Enrique,Kishimoto Mitsumasa,Salvarani Carlo,Damjanov Nemanja S,Anderson Jaclyn K,Blondell Erin,Zueger Patrick,Saffore Christopher,Strand Vibeke},
year={2021},
title={Improvement in Patient-Reported Outcomes in Patients With Psoriatic Arthritis With Inadequate Response to Non-Biologic DMARDs Treated With Upadacitinib Versus Placebo or Adalimumab: Results From a Phase 3 Study},
journal={JOURNAL OF RHEUMATOLOGY},
volume={48},
number={7},
pages={1168-1168},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Strand Vibeke,Mease Philip,Soriano Enrique,Kishimoto Mitsumasa,Salvarani Carlo,Damjanov Nemanja S,Anderson Jaclyn K,Blondell Erin,Zueger Patrick,Saffore Christopher,Gladman Dafna},
year={2020},
title={Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={},
pages={-},
document_type={Meeting Abstract},
} 

